The company launched Testosterone Rx+, a once-daily pill designed to help the body naturally increase testosterone levels. ・The rollout follows a recent FDA order supporting expanded testosterone ...

Eli Lilly and Company (NYSE: LLY) and Novo Nordisk A/S (NYSE: NVO) are two weight-loss and diabetes drug stocks that have ...

Telehealth company Hims & Hers on Monday announced a “strategic shift” in its business model, partnering with pharmaceutical company Novo Nordisk to sell its blockbuster GLP-1 medication and stop ...

Add Yahoo as a preferred source to see more of our stories on Google. Hims & Hers will now sell only the cheaper weight loss drugs at a limited scale, the company says. (Hims and Hers) Hims & Hers had ...

The FDA said it plans to restrict GLP-1 ingredients used in compounded drugs that companies such as Hims and online ...

Novo Nordisk faces missed guidance as FDA limits on compounded GLP-1s shift the market, while HIMS diversifies offerings.

The proposal could affect telehealth services that rely on outside facilities to produce the knockoff drugs in bulk.

Novo Nordisk and Hims & Hers have ended a legal feud with an agreement that allows the telehealth platform to sell the pharma giant’s blockbuster brand-name GLP-1 drugs. In separate statements issued ...

SAN FRANCISCO — Novo Nordisk is dismissing its patent infringement lawsuit against telehealth company Hims & Hers, as the two companies have reached an agreement that will see Novo Nordisk’s branded ...

Thu, March 12, 2026 at 2:46 PM UTC Then came the surprise truce announced last Friday: Novo dropped the lawsuit (while reserving the right to refile), and Hims agreed to sell branded Wegovy and ...

WASHINGTON(AP) — Telehealth company Hims & Hers said Thursday it will launch a cheaper, off-brand version of the weight-loss pill Wegovy, just weeks after drugmaker Novo Nordisk launched its highly ...

A majority of GLP-1 lawsuits come from patients who allege that manufacturers have inadequately warned about severe side ...